Commercial insight into the pharma and biotech sector.
Solutions for Investment Banking
Your clients rely on you for the best advice so you need the best in class data that only EvaluatePharma offers. With access to our unique analysis and insights you can identify potential targets, understand the strategic intent of companies, build pitch books, and respond quickly and confidently to the latest market developments – to propose the best solutions to your clients in the pharma and biotech sector.
- Understand market dynamics & therapy trends with standardized, detailed forecast models linked to forward-looking valuation measures that can be sifted, filtered and tied back to industry and product fundamentals
- Identify impending regulatory & market risks with Calendar of Events tracking & analyzing all future events that may impact company & product valuation, including product approvals, clinical trials, patent & litigation
- Model potential impact of industry events on company & product valuation with our interactive NPV Analyzer
- Gain new insights into market catalysts with EP Vantage daily alerts with forward-looking financial analysis and comment on regulatory and patent decisions, marketing approvals, licensing deals and M&A
- Assess the business logic of merger scenarios with our unique Merge tool & create virtual companies to react rapidly to merger announcements or market speculation
Discover more Solutions for Investment Banking